This article first appeared on GuruFocus.
Avantis U.S. Equity ETF (AVUS) added to its portfolio last Thursday, with net buying of $213.4 million against $226.2 million in gross ETF activity. The fund increased 434 positions and trimmed 537, with total assets of $14.67 billion.
What did AVUS buy on Thursday?
Its largest buys by dollar value were XOM ($201.7 million), MSFT ($1.9 million) and LLY ($1.6 million).
What did AVUS sell on Thursday?
Its largest sells by dollar value were LRCX ($0.2 million), MRK ($0.2 million) and COST ($0.2 million).
Exxon Mobil led the buys, a new position of 1,100,229 shares worth $201.7 million and 1.36% of assets. Microsoft added 3,584 shares for $1.9 million, Eli Lilly 1,155 shares for $1.6 million, and Apple and Meta Platforms $0.7 million each. The largest sells were small: Lam Research, Merck, Costco, Gilead Sciences and Caterpillar each saw reductions of $0.2 million or less, and no positions were fully exited.
How does AVUS invest?
Avantis U.S. Equity ETF (AVUS) is an Equity US fund holding 1,117 stocks, with 29.4% of assets in its top 10. Technology is its largest sector at 29.9%, followed by Financial Services at 16.2% and Consumer Cyclical at 10.7%. Large caps make up 90.5% of the mix, mid caps 8.5% and small caps 1.0%. It charges 0.15% and its top holdings are Apple at 5.93%, Nvidia at 5.43%, Microsoft at 4.7%, Amazon at 3.26% and Micron Technology at 2.2%. The fund has a GF Score of 86, a P/E of 19.28, a P/B of 3.44, a dividend yield of 0.92% and a year-to-date return of 15.44%.
Avantis U.S. Equity ETF (AVUS) at a glance
Source: finance.yahoo.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.
